Home
Myriad Genetics MYGN spent $260K on lobbying in Q1 2026 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $260,000
- Quarter
- Q1 2026
- Stock
- Myriad Genetics MYGN
- Client
- Myriad Genetics
- Reported
- 26/04/20
Up 4.0% from last quarter
What else happened in Myriad Genetics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Myriad Genetics's other lobbying reports
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$40K
$40K
Reported 07/20
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
Under $5,000
Under $5,000
Reported 07/20
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$40K
$40K
Reported 07/18
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$30K
$30K
Reported 07/17
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$10K
$10K
Reported 07/03
for Q2